Filter-related, Thrombotic Occlusion of the Inferior Vena Cava Treated with a Gianturco Stent

Joshi, Akash; Carr, James; Chrisman, Howard B.; Omary, Reed A.; Resnick, Scott A.; Saker, Marc; Nemcek, Albert A.; Vogelzang, Robert L.

doi:10.1097/01.rvi.0000058419.01661.01

Cited by 16 publications

(6 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fixation is achieved by means of short straight barbs in opposing directions, and centering is accomplished by the struts that connect the trapping surfaces. 12,13 The high radial force exerted by this device on deployment may also promote fixation. The TrapEase design was modified for retrieval by fabricating a hook on one apex to facilitate snaring during retrieval, and one of the opposing fixation barbs was removed from each of the struts.…”

Section: Resultsmentioning

confidence: 99%

Form And Function Of Vena Cava Filters: How Do Optional Filters Measure Up?

Proctor

Greenfield

2008

Vascular

View full text Add to dashboard Cite

The function of vena cava filters, preventing pulmonary embolism while maintaining caval patency, is associated with the design. Several characteristics have been reported. This report evaluates retrievable filter designs in comparison with previously marketed designs with respect to efficacy and safety. Three inferior vena cava (IVC) filters (Gunther Tulip, Bard Recovery, and the Cordis OptEase) were compared on the basis of design characteristics associated with function, shape, number of trapping levels, and fixation. Adverse events reported in the literature and to the US Food and Drug Administration Manufacturers and User Facility Device Experience Database (MAUDE) were summarized. The major differences among device types include the fixation, the volume and number of trapping levels, and the amount of metal in the IVC. The MAUDE registry reported adverse events that had been hypothesized from the analysis of in vitro and in vivo testing. The Recovery and OptEase filters had the highest number of clinically important reports. From 12 to 57% were retrieved between 3 days and 11 months. Adaptations made to facilitate retrieval led to unacceptable sequelae. The small number removed, the length of time they are left in place, and the risks associated with retrieval suggest that optional filters may not be equivalent to approved permanent devices.

show abstract

Section: Resultsmentioning

confidence: 99%

Form And Function Of Vena Cava Filters: How Do Optional Filters Measure Up?

Proctor

Greenfield

2008

Vascular

View full text Add to dashboard Cite

show abstract

“…In such cases, endovascular venoplasty and stenting can be attempted. Table summarizes the available studies and case reports that include endovascular venoplasty and stenting in the treatment of VCF thrombosis . The risks of balloon venoplasty and stenting of VCF thrombosis include IVC perforation, lead fracture, and PE.…”

Section: Discussionmentioning

confidence: 99%

Successful MitraClip® implantation after angioplasty of a chronic inferior vena cava filter thrombosis

Barbin

Grayburn

Choi

2015

Cathet Cardio Intervent

View full text Add to dashboard Cite

The MitraClip® has increasing use for severe, high surgical risk mitral regurgitation (MR). The MitraClip® is implanted percutaneously across the interatrial septum. Given the large diameter of the device delivery system, the femoral vein is the best option for central venous access. This is the first reported case of successful MitraClip® implantation through a chronically occluded IVC filter. © 2015 Wiley Periodicals, Inc.

show abstract

“…To maintain the fluency of the IVC, balloon dilation and stent implantation have been performed following the recanalization of chronic IVC thrombosis. Joshi et al reported that following thrombolysis, thrombectomy and percutaneous removal of the filter did not succeed and an expandable metallic Gianturco Z stent (Cook, Bloomington, IN, USA) was used to extract the TrapEase filter from the vessel lumen (27). In 25 patients with an obstructed IVC filter, following recanalization by a guide wire and balloon dilation, the filter was markedly displaced sidewise or remodeled (28).…”

Section: Discussionmentioning

confidence: 99%

Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter

Xiao

Shen

Tong

et al. 2012

Experimental and Therapeutic Medicine

View full text Add to dashboard Cite

Thrombus within an inferior vena cava (IVC) filter reduces filter patency and venous return from the lower extremities, and may progress to complete IVC occlusion. The clinical experiences and outcomes of transcatheter thrombolytic therapy for symptomatic IVC thrombosis following filter implantation have not been widely reported. The aim of the current study was to evaluate the efficiency and safety of trans-catheter thrombolysis for the treatment of symptomatic IVC thrombosis in patients with implanted IVC filters. Transcatheter thrombolysis was used to treat 5 patients with thrombosis of the filter-bearing IVC causing symptoms in 10 limbs from October 2005 to September 2010. The patients were implanted with a second IVC filter through the right internal jugular vein, followed by recanalization of the occluded IVC and intravenous transcatheter thrombolysis. The IVC filters were retrieved through the femoral or right internal jugular vein after the thrombus had dissolved. Technical and clinical outcome, complications and postoperative pulmonary embolism were monitored. A total of 5 filters were implanted and 6 filters were retrieved later. Technically and clinically successful recanalization and thrombolysis were achieved in 5 of 5 patients and 10 of 10 symptomatic limbs. The median thrombolysis period was 13 days (range, 8–14 days). The median dwell time for the filters that were removed was 50.5 days (range, 14–73 days). No major bleeding occurred during the current study. During clinical follow-up, no clinically detectable pulmonary embolism was observed. Endovascular recanalization and transcatheter thrombolysis of IVC thrombosis are efficient, feasible and safe in the presence of an IVC filter.

show abstract

Filter-related, Thrombotic Occlusion of the Inferior Vena Cava Treated with a Gianturco Stent

Cited by 16 publications

References 15 publications

Form And Function Of Vena Cava Filters: How Do Optional Filters Measure Up?

Form And Function Of Vena Cava Filters: How Do Optional Filters Measure Up?

Successful MitraClip® implantation after angioplasty of a chronic inferior vena cava filter thrombosis

Transcatheter thrombolytic therapy for symptomatic thrombo-occlusion of inferior vena cava filter

Contact Info

Product

Resources

About